biosurfit press / news

Find out more about the latest news and updates of biosurfit.

Appointment of Gordon Powell as Advisory Board Member

biosurfit, a rapidly-growing company focused on the Point of Care medical diagnostic market, is pleased to announce today the appointment of Mr. Gordon Powell as an Advisory Board Member.

 

Mr. Gordon Powell brings with him over 20 years of sales and marketing experience in the global in-vitro diagnostics industry. Most recently Gordon was the Group Marketing Director at Axis-Shield based in London and before then he was Marketing Director for the launch of the Afinion™ point of care system in the United States and was based at the Axis-Shield office in Boston. Gordon is currently based in Glasgow, UK and is the CEO of Qnostics Ltd. who are a leading provider of controls for the molecular diagnostics industry. He holds a Post Graduate Diploma in Marketing and is a member of the Chartered Institute of Marketing.

 

Commenting on his appointment, Gordon Powell said: “I am delighted to be able to take up this appointment with biosurfit at such an important time in their development. biosurfit is already widely respected and recognized for their innovative point of care technology and I am delighted to be able to advise on their launch strategy going forward. I am proud to take on this role and am looking forward to working with the rest of the team.”

 

Daniel Neves, Co-founder and CMO of biosurfit, commented, “We are delighted to have Gordon working with us. His experience and network in the IVD and especially in the POC industry will be of a great value as we continue to implement our Go-to-market strategy. It’s never been more important for us to hear from experience and our hope is that it will enable us to make smarter choices in our coverage of the market.”

 

About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to delivers precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

 

For more information, please contact:

 

Daniel Neves, CMO of biosurfit, phone: +351 217500228

biosurfit renews the CE Marking for spinit® CRP
now with improved performance

biosurfit renewed the CE marking for the spinit® CRP with improved performance. With the updated system, the spinit® is able to quantify the CRP in an extended range and with improved precision. Furthermore, the spinit® uses advanced an internal Quality Control system with positive and negative controls for enhanced performance.

 

About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

For more information, please contact:

Daniel Neves, CMO of biosurfit, tel: +351 217500228

CE

biosurfit singled out
by TV news program “Falar Global”

biosurfit, was singled out by the TV News channel “SIC Noticias” in their program “Falar Global”. biosurfit was highlighted as one of a few examples of a Portuguese startup company in the healthcare business going global.

 

See the full video on the SIC website:
http://sicnoticias.sapo.pt/arquivo/2012-11-03-medicina-tecnologica-anti-crise

 

About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

 

For more information, please contact:

Daniel Neves, CMO of Biosurfit, tel: +351 217500228

biosurfit announces a third successful surveillance audit
for the in vitro medical device standard ISO13485:2012,
demonstrating its strong commitment to continuous improvement.

Maintaining ISO 13485 and ISO 9001 certification is an important milestone and distinguishing differentiator for biosurfit. It demonstrates to our customers, collaborators and business partners, that we are dedicated to quality at every level of the organization.

 

“Every member of the biosurfit team takes an active role in following and supporting our quality policies, allowing us to lead the way in addressing current and future requirements of the clinical diagnostics market” said CEO, João Garcia da Fonseca.

 

This certification is crucial to medical device companies to create a standardized quality system for the design and manufacture of medical devices that meet both customer and regulatory requirements. The review was performed by TÜV Rheinland according to ISO 13485:2003 requirements, and focused on biosurfit´s design, manufacturing of the spinit® reader and test specific disposable disk cartridges.

 

The one day visit by an independent auditor included a review of core and supporting quality management procedures, manufacturing and quality control processes as well as customer related processes. In addition to checking for compliance with the ISO standards, this surveillance audit was also an opportunity to expand the scope of the company´s certification to include installation and servicing activities not previously covered by the Quality Management System.

 

“The ISO 13485 certification makes us stronger as a company and builds the level of confidence our customers are expecting from our products We are committed to delivering only products manufactured with the highest level of traceability and quality control.” added biosurfit´s Quality System Manager, Claudia Ferreira.

 

About biosurfit
biosurfit develops innovative medical diagnostics solutions in order to improve physician performance, by providing real-time and accurate results for blood analysis. Its core product is spinit®, a user-friendly reader that combined with a disposable cartridge uses one small drop of blood to give precise results within 10-15 minutes for multi-parameter test panels.

 

About TÜV-Rheinland
TÜV Rheinland is a leading international service provision group with 500 locations in 61 countries on all continents. In its role as an independent, neutral third party, TÜV Rheinland tests, monitors, develops, promotes and certifies products, equipment, processes and management systems as well as services on the basis of statutory specifications and other relevant performance benchmarks and standards.

For more information, please contact:

Claudia Ferreira, Quality System Manager of biosurfit, tel: +351 217500228

biosurfit singled out
by the Vision Systems Design Magazine

biosurfit, was singled out by the Vision Systems Design magazine in regards to spinit® blood diagnostic system.

 

Using a combination of imaging cameras, proprietary software and CD-like test cartridges, the spinit® takes one small drop of blood, analyses it, and gives precise results within 10-15 minutes. The CD-like cartridge in the spinit® incorporates several detection zones that include a biological recognition layer (BRL) containing antibody fragments immobilized on a gold surface that acts as a selective trap for a specific blood biomarker.
Read the full article on the Vision Systems Design website.

 

About biosurfit
biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

For more information, please contact:

Daniel Neves, CMO of biosurfit, tel: +351 217500228